Latest Articles
New endometriosis pill on the NHS could benefit more than 1,000 women a year - Health Tech World
New endometriosis pill on the NHS could benefit more than 1,000 women a year Health Tech World
Published: May 5, 2025, 11:03 a.m.
Refinery29 Loves: Everything To See & Shop In May - MSN
Refinery29 Loves: Everything To See & Shop In May MSN
Published: May 4, 2025, 7:29 a.m.
New endometriosis pill on the NHS could benefit more than 1,000 women a year - Wired-Gov
New endometriosis pill on the NHS could benefit more than 1,000 women a year Wired-Gov
Published: May 2, 2025, 8:14 a.m.
Wagamama commits to become endometriosis-friendly employer - employeebenefits.co.uk
Wagamama commits to become endometriosis-friendly employer employeebenefits.co.uk
Published: May 1, 2025, 9:11 a.m.
Up to 1,000 women a year could benefit from new at-home treatment for endometriosis - NICE website
Up to 1,000 women a year could benefit from new at-home treatment for endometriosis NICE website
Published: April 30, 2025, 11 p.m.
Mismatch Repair-Deficient FIGO Stage IA Endometrial Adenocarcinoma With Negative Nodal Biopsy Presenting as Isolated Orbital Metastasis - Cureus
Mismatch Repair-Deficient FIGO Stage IA Endometrial Adenocarcinoma With Negative Nodal Biopsy Presenting as Isolated Orbital Metastasis Cureus
Published: April 30, 2025, 12:42 a.m.
Robotic Laparoscopy Beneficial in Endometrial Cancer - Physician's Weekly
Robotic Laparoscopy Beneficial in Endometrial Cancer Physician's Weekly
Published: April 29, 2025, 8:46 p.m.
Endometrial Ablation Market to Benefit from Technological Innovations and Healthcare Modernization - openPR.com
Endometrial Ablation Market to Benefit from Technological Innovations and Healthcare Modernization openPR.com
Published: April 24, 2025, 6:22 a.m.
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling - MSN
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling MSN
Published: April 19, 2025, 1:26 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …
Published: April 18, 2025, 5:25 a.m.
Link copied to clipboard!